Table S2 from HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
收藏数据链接:
官方服务:
资源简介:
Binding activity of HRA00129-C004 to human FcRn
创建时间:
2026-03-02

Binding activity of HRA00129-C004 to human FcRn